Saatja: <
[email protected]>
Saadetud: 16.02.2023 12:01
Teema: WHO: C.L.3.2023 Special Session of the Executive Board - 6 March 2023
Manused: C.L.3.2023 EBSS6 (English).pdf; C.L.3.2023 EBSS6 (Arabic).pdf; C.L.3.2023
EBSS6 (Chinese).pdf; C.L.3.2023 EBSS6 (French).pdf; C.L.3.2023 EBSS6 (Russian).pdf;
C.L.3.2023 EBSS6 (Spanish).pdf
Dear WHO Member States,
Please find attached, in the six official languages, C.L.3.2023 regarding the Special Session of
the Executive Board which will be convened on 6 March 2023.
Best regards,
Department of Governing Bodies
World Health Organization
***DO NOT RESPOND TO THIS E-MAIL. YOU WILL NOT RECEIVE A REPLY***
20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT
Ref.: C.L.3.2023
The Director-General of the World Health Organization (WHO) presents his compliments
to Member States and Associate members and has the honour to inform them that following
consultation with the Chair of the Executive Board, Members of the Executive Board are invited
to the Special Session of the Executive Board on the outcome of the investigation process in
respect of allegations concerning the Regional Director for the Western Pacific Region.1
The Special Session of the Executive Board will be held at WHO headquarters in Geneva,
Switzerland, on Monday, 6 March 2023, with provision to extend the session until
7 March 2023, if necessary. The working hours will be 09:30 to 12:30 and 14:30 to 17:30.
Online registration is required to attend the Special Session of the Executive Board.
Registration can be initiated as of 20 February 2023 by going to the following link:
https://indico.un.org/e/EBSS/6.
The provisional agenda for the Special Session of the Executive Board is available in
document EBSS/6/1.
As decided by the Executive Board at its 152nd session through decision EB152(14)
(2023), the following modalities will apply to the Special Session of the Executive Board, unless
otherwise decided by the Executive Board:
₋ Given the sensitive nature of the subject matter, the Special Session will take place in
person in Geneva and be held in restricted format under Rule 7(c) of the Rules of
Procedure of the Executive Board, with attendance restricted to Members of the Board,
accompanied by up to two alternates or advisers each, and essential Secretariat staff
only.
₋ Unless otherwise decided, all documentation for, and discussion at, the Special Session
will be treated as strictly confidential and will be made available only to Members of
the Board and their delegations.
₋ The Secretariat will provide a report (the same as provided to a special session of the
Regional Committee for the Western Pacific, if any) for consideration at the Special
Session of the Board, at least three weeks before the opening of the special session,
through a secure online platform. The report will be made available in the six official
languages.
1
Decision EB152(14) (2023).
Page 2
C.L.3.2023
₋ Supporting documents, comprising the relevant investigation reports, transcripts of the
interviews on which they are based, reports of the WHO Global Advisory Committee
on formal complaints of abusive conduct, relevant charge letters and the Regional
Director’s responses will also be provided to delegates attending the Special Session
through the secure online platform. The supporting documents will be made available in
the original language (English) only at least three weeks before the opening of the
special session. Where necessary to protect the identities of individuals, these
documents will be redacted to the extent possible. Access to the secure online platform
will be provided to up to three persons per delegation upon request in accordance with
instructions set in this convocation notice.
₋ The outcome of the special session of the Regional Committee for the Western Pacific
would be conveyed to the Board separately before the opening of the special session of
the Board.
In order to access the secure online platform on which the documents will be posted,
permission must be granted to individuals. To enable such access to be granted, Members of the
Board are invited to communicate the name, position and email address of up to three persons to
whom access should be granted to
[email protected].
The Director-General of the World Health Organization takes this opportunity to renew to
Member States and Associate members the assurance of his highest consideration.
GENEVA, 15 February 2023